SEOM clinical guideline for the management of malignant melanoma (2017)

被引：12

作者：

Berrocal, A. ^{[1
]}

Arance, A. ^{[2
]}

Castellon, V. E. ^{[3
]}

de la Cruz, L. ^{[4
]}

Espinosa, E. ^{[5
]}

Cao, M. G. ^{[6
]}

Larriba, J. L. G. ^{[7
]}

Marquez-Rodas, I. ^{[8
]}

Soria, A. ^{[9
]}

Algarra, S. M. ^{[10
]}

机构：

[1] Consorcio Hosp Gen Univ Valencia, Med Oncol Serv, Avda Tres Cruces 2, Valencia 46014, Spain

[2] Hosp Clin Barcelona, Barcelona, Spain

[3] Hosp Torrecardenas, Almeria, Spain

[4] Complejo Hosp Reg Virgen Macaren, Seville, Spain

[5] Hosp Univ La Paz, Madrid, Spain

[6] Hosp Univ Quiron Dexeus, Barcelona, Spain

[7] Hosp Univ Clin San Carlos, Madrid, Spain

[8] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[9] Hosp Univ Ramon y Cajal, Madrid, Spain

[10] Clin Univ Navarra, Pamplona, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2018年 / 20卷 / 01期

关键词：

Melanoma; Metastatic; Adjuvant; Immunotherapy; B-RAF; OPEN-LABEL; HIGH-RISK; BRAF; IPILIMUMAB; NIVOLUMAB; SURVIVAL; PEMBROLIZUMAB; MULTICENTER; VEMURAFENIB; INTERFERON;

D O I：

10.1007/s12094-017-1768-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

All melanoma suspected patients must be confirmed histologically and resected. Sentinel node biopsy must be done when tumor is over 1 mm or if less with high-risk factors. Adjuvant therapy with interferon could be offered for patients with high-risk melanoma and in selected cases radiotherapy can be added. Metastatic melanoma treatment is guided by mutational BRAF status. BRAF wild type patients must receive anti-PD1 containing therapy and BRAF mutated patients BRAF/MEK inhibitors or anti-PD1 containing therapy. Up to 10 years follow up is reasonable for melanoma patients with dermatologic examinations and physical exams.

引用

页码：69 / 74

页数：6

共 50 条

[1] SEOM clinical guideline for the management of malignant melanoma (2017)
A. Berrocal
A. Arance
V. E. Castellon
L. de la Cruz
E. Espinosa
M. G. Cao
J. L. G. Larriba
I. Márquez-Rodas
A. Soria
S. M. Algarra
[J]. Clinical and Translational Oncology, 2018, 20 : 69 - 74
[2] SEOM clinical guideline for the management of cutaneous melanoma (2020)
M. Majem
J. L. Manzano
I. Marquez-Rodas
K. Mujika
E. Muñoz-Couselo
E. Pérez-Ruiz
L. de la Cruz-Merino
E. Espinosa
M. Gonzalez-Cao
A. Berrocal
[J]. Clinical and Translational Oncology, 2021, 23 : 948 - 960
[3] SEOM clinical guideline for the management of cutaneous melanoma (2020)
Majem, M.
Manzano, J. L.
Marquez-Rodas, I.
Mujika, K.
Munoz-Couselo, E.
Perez-Ruiz, E.
de la Cruz-Merino, L.
Espinosa, E.
Gonzalez-Cao, M.
Berrocal, A.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (05): : 948 - 960
[4] SEOM clinical guideline in nasopharynx cancer (2017)
M. Pastor
A. Lopez Pousa
E. del Barco
P. Perez Segura
B. Gonzalez Astorga
B. Castelo
T. Bonfill
J. Martinez Trufero
J. Jose Grau
R. Mesia
[J]. Clinical and Translational Oncology, 2018, 20 : 84 - 88
[5] SEOM clinical guideline in nasopharynx cancer (2017)
Pastor, M.
Lopez Pousa, A.
del Barco, E.
Perez Segura, P.
Gonzalez Astorga, B.
Castelo, B.
Bonfill, T.
Martinez Trufero, J.
Jose Grau, J.
Mesia, R.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 84 - 88
[6] SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
J. M. Sepúlveda-Sánchez
J. Muñoz Langa
M. Á. Arráez
J. Fuster
A. Hernández Laín
G. Reynés
V. Rodríguez González
E. Vicente
M. Vidal Denis
Ó. Gallego
[J]. Clinical and Translational Oncology, 2018, 20 : 3 - 15
[7] SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
Sepulveda-Sanchez, J. M.
Munoz Langa, J.
Arraez, M. A.
Fuster, J.
Hernandez Lain, A.
Reynes, G.
Rodriguez Gonzalez, V.
Vicente, E.
Vidal Denis, M.
Gallego, O.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 3 - 15
[8] SEOM guidelines for the management of Malignant Melanoma 2015
Berrocal, A.
Arance, A.
Espinosa, E.
Castano, A. G.
Cao, M. G.
Larriba, J. L. G.
Martin, J. A. L.
Marquez, I.
Soria, A.
Algarra, S. M.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 1030 - 1035
[9] SEOM guidelines for the management of Malignant Melanoma 2015
A. Berrocal
A. Arance
E. Espinosa
A. G. Castaño
M. G. Cao
J. L. G. Larriba
J. A. L. Martín
I. Márquez
A. Soria
S. M. Algarra
[J]. Clinical and Translational Oncology, 2015, 17 : 1030 - 1035
[10] SEOM clinical guideline for treatment of kidney cancer (2017)
Gallardo, E.
Mendez-Vidal, M. J.
Perez-Gracia, J. L.
Sepulveda-Sanchez, J. M.
Campayo, M.
Chirivella-Gonzalez, I.
Garcia-del-Muro, X.
Gonzalez-del-Alba, A.
Grande, E.
Suarez, C.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 47 - 56

← 1 2 3 4 5 →